Why is Sotac Pharma. falling/rising?

As of 02-Sep, Sotac Pharmaceuticals Ltd is currently priced at 137.55, showing no change (0.00%). The stock has been performing inline with its sector today, and it is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Notably, there has been a significant increase in investor participation, with delivery volume rising by 246.15% compared to the 5-day average. Over the past month, the stock has increased by 10.04%, while year-to-date it has risen by 25.85%. However, despite these positive movements, the stock has experienced a decline of 11.26% over the past year, which is concerning. The company's return on capital employed (ROCE) stands at 8.1, indicating an attractive valuation, but the high debt to EBITDA ratio of 2.52 times raises concerns about its ability to service debt. In the broader market context, the Sensex has decreased by 0.54% over the past week, while Sotac Pharmaceuticals has remained flat, suggesting that the stock is holding its ground relative to the market. The stock's performance over the last month has outpaced the benchmark, which has only increased by 0.06%. However, the company's long-term fundamental strength appears weak, as it has not declared results in the last six months and has shown poor long-term growth with net sales growing at an annual rate of only 11.90% over the past five years. While profits have risen by 79%, the flat results in June 2024 and the negative annual return could be contributing to investor caution, despite the recent positive price movements.